Saudi Arabia Fondaparinux Market Size & Outlook, 2025-2030
Related Markets
Saudi Arabia fondaparinux market highlights
- The Saudi Arabia fondaparinux market generated a revenue of USD 2.3 million in 2024 and is expected to reach USD 3.1 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 4.8% from 2025 to 2030.
- In terms of segment, deep vein thrombosis was the largest revenue generating type in 2024.
- Pulmonary Embolism is the most lucrative type segment registering the fastest growth during the forecast period.
Fondaparinux market data book summary
| Market revenue in 2024 | USD 2.3 million |
| Market revenue in 2030 | USD 3.1 million |
| Growth rate | 4.8% (CAGR from 2025 to 2030) |
| Largest segment | Deep vein thrombosis |
| Fastest growing segment | Pulmonary Embolism |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Deep Vein Thrombosis, Pulmonary Embolism |
| Key market players worldwide | Abbott Laboratories, Alchemia, Apotex Inc., GSK PLC ADR, Lupin Pharmaceuticals, ScinoPharm Taiwan, Dr Reddy's Laboratories Ltd ADR, Bayer HealthCare, GlaxoSmithKline, Boehringer Ingelheim, Sanofi SA, Wismed, Kaifeng, Mylan |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.3% of the global fondaparinux market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa fondaparinux market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 1.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Fondaparinux Market Scope
Fondaparinux Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Kaifeng | View profile | 501-1000 | Hangzhou, Zhejiang, China, Asia | https://www.nb-kaifeng.com |
| Wismed | View profile | - | Beijing, Beijing, China, Asia | https://www.wismed.com.cn |
| ScinoPharm Taiwan | View profile | 501-1000 | Tainan, T'ai-wan, Taiwan, Asia | http://www.scinopharm.com/ |
| Alchemia | View profile | 1-10 | Eight Mile Plains, Queensland, Australia, Oceania | http://www.alchemia.com.au/ |
| Lupin Pharmaceuticals | View profile | 501-1000 | Baltimore, Maryland, United States, North America | http://www.lupinpharmaceuticals.com |
| Bayer HealthCare | View profile | 10001+ | Leverkusen, Nordrhein-Westfalen, Germany, Europe | http://www.bayerhealthcare.com |
| Apotex Inc. | View profile | 10001+ | Toronto, Ontario, Canada, North America | http://www.apotex.com |
| Mylan | View profile | 10001+ | https://www.mylan.in/ | |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| GSK PLC ADR | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Dr Reddy's Laboratories Ltd ADR | View profile | 22822 | 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, India, 500 034 | https://www.drreddys.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Saudi Arabia fondaparinux market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fondaparinux market will help companies and investors design strategic landscapes.
Deep vein thrombosis was the largest segment with a revenue share of 65.22% in 2024. Horizon Databook has segmented the Saudi Arabia fondaparinux market based on deep vein thrombosis, pulmonary embolism covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Saudi Arabia fondaparinux market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia fondaparinux market databook
-
Our clientele includes a mix of fondaparinux market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia fondaparinux market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia fondaparinux market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia fondaparinux market size, by distribution channel, 2018-2030 (US$M)
Saudi Arabia Fondaparinux Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
